Use of cyfra 21-1 as a marker for colorectal cancer

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01)

Patent

CA 2585788

The present invention relates to the assessment of colorectal cancer. It discloses the use of the CYFRA 21-1 assay in the assessment of colorectal cancer. It also relates to a method for assessing colorectal cancer in vitro using a liquid sample, derived from an individual by measuring CYFRA 21-1 in said sample. Measurement of CYFRA 21-1 can, e.g., be used in the early detection or in the follow-up of patients with colorectal cancer.

L'invention concerne l'évaluation du cancer colorectal. Elle se réfère à l'utilisation du dosage de CYFRA 21-1 dans l'évaluation du cancer colorectal, et à un procédé in vitro d'évaluation du cancer colorectal à l'aide d'un échantillon liquide prélevé sur un sujet, le procédé consistant à mesurer CYFRA 21-1 dans ledit échantillon. La mesure de CYFRA 21-1 est utile, par exemple, dans la détection précoce du cancer colorectal ou le suivi de patients atteints de cancer colorectal.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of cyfra 21-1 as a marker for colorectal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cyfra 21-1 as a marker for colorectal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cyfra 21-1 as a marker for colorectal cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2044474

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.